PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. (Q37200863)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 September 2013
edit
Language Label Description Also known as
English
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.
scientific article published on 03 September 2013

    Statements

    PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. (English)
    0 references
    Paolo Neviani
    Jason G Harb
    Joshua J Oaks
    Ramasamy Santhanam
    Christopher J Walker
    Justin J Ellis
    Gregory Ferenchak
    Adrienne M Dorrance
    Carolyn A Paisie
    Anna M Eiring
    Yihui Ma
    Hsiaoyin C Mao
    Bin Zhang
    Mark Wunderlich
    Philippa C May
    Chaode Sun
    Sahar A Saddoughi
    Jacek Bielawski
    William Blum
    Rebecca B Klisovic
    Janelle A Solt
    John C Byrd
    Stefano Volinia
    Jorge Cortes
    Claudia S Huettner
    Tessa L Holyoake
    Steven Devine
    Michael A Caligiuri
    Carlo M Croce
    Ramiro Garzon
    Besim Ogretmen
    Ralph B Arlinghaus
    Ching-Shih Chen
    Robert Bittman
    Peter Hokland
    Denis-Claude Roy
    Dragana Milojkovic
    Jane Apperley
    John M Goldman
    Alistair Reid
    James C Mulloy
    Ravi Bhatia
    Guido Marcucci
    Danilo Perrotti
    3 September 2013
    123
    4144-4157

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit